Shanghai Heartcare Medical Technology Corp. Ltd. Class H

As of December 31, 2025, Shanghai Heartcare Medical Technology Corp. Ltd. Class H carries a market capitalization of 2.02B, placing it among publicly traded companies globally. Its enterprise value stands at 1.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H's next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 37.68M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Shanghai Heartcare Medical Technology Corp. Ltd. Class H maintains a current ratio of 11.49, meaning it holds 11.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Shanghai Heartcare Medical Technology Corp. Ltd. Class H's stock has declined approximately 4.30% over the past 52 weeks. The 50-day moving average sits at 52.15, while the 200-day moving average is 49.53.

As of December 31, 2025, Shanghai Heartcare Medical Technology Corp. Ltd. Class H holds 875.26M in cash and equivalents against 47.54M in total debt, resulting in a net debt position of -656.23M. Total book value stands at 1.26B, with working capital of 1.10B providing operational flexibility.